[go: up one dir, main page]

ZA87309B - - Google Patents

Info

Publication number
ZA87309B
ZA87309B ZA87309A ZA87309A ZA87309B ZA 87309 B ZA87309 B ZA 87309B ZA 87309 A ZA87309 A ZA 87309A ZA 87309 A ZA87309 A ZA 87309A ZA 87309 B ZA87309 B ZA 87309B
Authority
ZA
South Africa
Prior art keywords
thiochroman
chroman
racemic
chiral
hydroxy
Prior art date
Application number
ZA87309A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ZA87309B publication Critical patent/ZA87309B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA87309A 1986-01-17 1987-01-16 ZA87309B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000091 WO1987004344A1 (en) 1986-01-17 1986-01-17 Hydroxyacetic acid derivatives for the treatment of diabetic complications

Publications (1)

Publication Number Publication Date
ZA87309B true ZA87309B (sh) 1988-07-18

Family

ID=22195340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87309A ZA87309B (sh) 1986-01-17 1987-01-16

Country Status (26)

Country Link
US (1) US4853410A (sh)
EP (1) EP0230379B1 (sh)
JP (1) JPS62169775A (sh)
KR (1) KR890004104B1 (sh)
CN (1) CN1015545B (sh)
AT (1) ATE62237T1 (sh)
AU (1) AU574001B2 (sh)
CA (1) CA1283119C (sh)
DD (1) DD266735A5 (sh)
DE (1) DE3768966D1 (sh)
DK (1) DK21687A (sh)
EG (1) EG18353A (sh)
ES (1) ES2022319B3 (sh)
FI (1) FI94636C (sh)
GR (1) GR3001863T3 (sh)
HU (1) HU206618B (sh)
IE (1) IE59450B1 (sh)
IL (1) IL81261A (sh)
NO (1) NO171411C (sh)
NZ (1) NZ218970A (sh)
PH (2) PH22231A (sh)
PL (1) PL148082B1 (sh)
PT (1) PT84107B (sh)
WO (1) WO1987004344A1 (sh)
YU (1) YU46042B (sh)
ZA (1) ZA87309B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
AU2440599A (en) * 1998-02-25 1999-09-15 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
AT502844B1 (de) * 2005-12-12 2007-08-15 Fronius Int Gmbh Schweissbrenner und endstück sowie kontaktrohr für einen schweissbrenner
CN102171200B (zh) * 2008-10-02 2015-09-30 坎布雷卡尔斯库加公司 用于制备二酮类和药物的方法
CN105924425B (zh) * 2016-04-29 2018-06-05 浙江师范大学 一种制备二氢硫色满衍生物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359161A (en) * 1963-08-29 1967-12-19 Kefalas As Thiaxanthenols, process of producing and anti-tussive compositions thereof
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds

Also Published As

Publication number Publication date
FI873843A (fi) 1987-09-04
DK21687D0 (da) 1987-01-16
EP0230379A3 (en) 1988-10-05
FI94636B (fi) 1995-06-30
DK21687A (da) 1987-07-18
NO171411C (no) 1993-03-10
CN1015545B (zh) 1992-02-19
PT84107B (pt) 1989-07-31
CN87100191A (zh) 1987-09-09
PH24703A (en) 1990-10-01
ES2022319B3 (es) 1991-12-01
PH22231A (en) 1988-07-01
US4853410A (en) 1989-08-01
AU574001B2 (en) 1988-06-23
HUT48230A (en) 1989-05-29
PL263678A1 (en) 1988-04-14
NO873854D0 (no) 1987-09-15
EP0230379B1 (en) 1991-04-03
NO171411B (no) 1992-11-30
NO873854L (no) 1987-09-15
DD266735A5 (de) 1989-04-12
JPH0586952B2 (sh) 1993-12-14
EG18353A (en) 1993-02-28
JPS62169775A (ja) 1987-07-25
WO1987004344A1 (en) 1987-07-30
PT84107A (en) 1987-02-01
ATE62237T1 (de) 1991-04-15
EP0230379A2 (en) 1987-07-29
DE3768966D1 (de) 1991-05-08
AU6764187A (en) 1987-07-30
IL81261A0 (en) 1987-08-31
KR870007149A (ko) 1987-08-17
IL81261A (en) 1992-05-25
NZ218970A (en) 1988-11-29
HU206618B (en) 1992-12-28
GR3001863T3 (en) 1992-11-23
PL148082B1 (en) 1989-09-30
IE59450B1 (en) 1994-02-23
YU46042B (sh) 1992-12-21
CA1283119C (en) 1991-04-16
IE870131L (en) 1987-07-17
FI873843A0 (fi) 1987-09-04
YU5787A (en) 1988-04-30
FI94636C (fi) 1995-10-10
KR890004104B1 (ko) 1989-10-20

Similar Documents

Publication Publication Date Title
FI861673L (fi) Menetelmä uusien ihmisen kudosplasminogeeniaktivaattorimutanttien valmistamiseksi
GB8806737D0 (en) Therapeutic composition & method
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
YU194088A (en) Process for obtaining substituted tetralins, chromanes and familiar racemic or optical active compounds
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
HUT54345A (en) Process for producing new, antiarrhythmic, sulfur-containing cyanophenol derivatives and medical compositions comprising same
ZA87309B (sh)
HUT55990A (en) Process for producing pharmaceutical compositions containing optically pure r-(-)-niguldipine and derivatives utilizable for treating tumors
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
GR3025530T3 (en) Antihypertensive benzopyran derivatives
AU3709289A (en) Strontium salt
NO169717C (no) Fremgangsmaate for fremstilling av et stabilt hydrat av etpenicillinderivat.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
AU7719491A (en) Therapeutic compound
ATE46908T1 (de) Verfahren zur herstellung von 4,5-dihydrodithieno(3,4b:3',4'-e>-azepin-5,9-dion.
HU904166D0 (en) Process for producing (+)-(2s,3s)-3-hydroxi-2-(4-methoxy-phenyl)-2,3-dihydro-5h-1,5-benzotriazepine-4-one derivatives
AU2203288A (en) Cooling tower treatment
IE880151L (en) Method for treatment of hyperacidity.